RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tarsus Pharmaceuticals Stock

Tarsus Pharmaceuticals Employees 2025

Tarsus Pharmaceuticals Employees

46

Ticker

TARS

ISIN

US87650L1035

In 2025, Tarsus Pharmaceuticals employed 46 people, a 0% change from the 46 number of employees in the previous year.

Tarsus Pharmaceuticals Aktienanalyse

What does Tarsus Pharmaceuticals do?

Tarsus Pharmaceuticals Inc is an emerging pharmaceutical company specializing in the development of novel therapies for eye diseases. The company was founded in 2016 and is headquartered in Irvine, California. Tarsus focuses on identifying groundbreaking innovative technologies and drugs for the treatment of eye diseases. Tarsus's business model is based on the idea that there are still no effective treatment methods for many eye diseases. For this reason, the company invests in research and development to close this gap and give affected patients new hope. Tarsus's goal is to improve eye health through the development of drugs and therapies. Tarsus is divided into several divisions that focus on different areas of ophthalmology. These include the development of drugs for the treatment of dry eyes, eyelid twitching, age-related macular degeneration, and other eye diseases. Tarsus's first product, TP-03, is a medication for the treatment of conjunctivitis caused by the bacterium Demodex. This condition affects millions of people worldwide and is often difficult to treat. TP-03 is a novel medication specifically targeting Demodex, thus providing an effective treatment option. Another product from Tarsus is TP-04, a medication for the treatment of dry eyes. This condition is one of the most common eye diseases worldwide, affecting millions of people. TP-04 aims to combat the causes of dry eyes and alleviate the symptoms. Tarsus also has a promising pipeline of products in various stages of development. These include medications for age-related macular degeneration, eyelid twitching, and other eye diseases. Tarsus has entered into partnerships with major pharmaceutical companies and research institutions. These partnerships allow the company to bring its products to market faster and reach a larger audience. Overall, Tarsus has the potential to revolutionize ophthalmology and improve the treatment of many eye diseases. The company has a dedicated team of researchers and scientists who are committed to advancing the development of new therapies and medications. Tarsus Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Tarsus Pharmaceuticals's Employee Base

Tarsus Pharmaceuticals's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Tarsus Pharmaceuticals's operational capacity and future potential.

Year-to-Year Comparison

Assessing Tarsus Pharmaceuticals's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Tarsus Pharmaceuticals's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Tarsus Pharmaceuticals’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Tarsus Pharmaceuticals stock

How many employees does Tarsus Pharmaceuticals have this year?

Tarsus Pharmaceuticals has 46 undefined employees this year.

How many employees did Tarsus Pharmaceuticals have compared to the previous year?

Compared to the previous year, Tarsus Pharmaceuticals had 0% more employees.

What impact did the number of employees have on the company Tarsus Pharmaceuticals?

The number of employees has a direct impact on the efficiency and productivity of Tarsus Pharmaceuticals. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Tarsus Pharmaceuticals?

The number of employees can also have an impact on investors of Tarsus Pharmaceuticals, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Tarsus Pharmaceuticals affect the company?

An increase in equity of Tarsus Pharmaceuticals can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Tarsus Pharmaceuticals's equity affect the company?

A reduction in equity of Tarsus Pharmaceuticals can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Tarsus Pharmaceuticals?

Some factors that can influence the equity of Tarsus Pharmaceuticals include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Tarsus Pharmaceuticals so important for investors?

The equity of Tarsus Pharmaceuticals is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Tarsus Pharmaceuticals influence the company?

The number of employees at Tarsus Pharmaceuticals can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Tarsus Pharmaceuticals evolved in recent years?

In recent years, the number of employees at Tarsus Pharmaceuticals has changed by 0.

How many employees does Tarsus Pharmaceuticals currently have?

Tarsus Pharmaceuticals currently has 46 undefined employees.

Why is the number of employees important for investors of Tarsus Pharmaceuticals?

The number of employees is important for investors of Tarsus Pharmaceuticals as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Tarsus Pharmaceuticals take to change the number of employees?

To change the number of employees, Tarsus Pharmaceuticals can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Tarsus Pharmaceuticals pay?

Over the past 12 months, Tarsus Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tarsus Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Tarsus Pharmaceuticals?

The current dividend yield of Tarsus Pharmaceuticals is .

When does Tarsus Pharmaceuticals pay dividends?

Tarsus Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Tarsus Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tarsus Pharmaceuticals located?

Tarsus Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tarsus Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tarsus Pharmaceuticals from 2/22/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/22/2025.

When did Tarsus Pharmaceuticals pay the last dividend?

The last dividend was paid out on 2/22/2025.

What was the dividend of Tarsus Pharmaceuticals in the year 2024?

In the year 2024, Tarsus Pharmaceuticals distributed 0 USD as dividends.

In which currency does Tarsus Pharmaceuticals pay out the dividend?

The dividends of Tarsus Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Tarsus Pharmaceuticals

Our stock analysis for Tarsus Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tarsus Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.